Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

922
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
922
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

391
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
391
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

223
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
223
Decreasing Function01:27

Decreasing Function

241
A decreasing function describes a relationship where the output consistently declines as the input increases. This means that for any two input values, if one is greater than the other, the corresponding output is smaller. Mathematically, a function f is decreasing on an interval I if for every x1 < x2​ in I, f (x1) > f (x2). This type of behavior is visually identified on a graph that slopes downward from left to right.The nature of a function can be analyzed by calculating...
241
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

345
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
345
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

609
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
609

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring theoretical policy options for reducing socioeconomic inequalities in multimorbidity: A microsimulation study in England from 2019-2049.

Journal of multimorbidity and comorbidity·2026
Same author

Daily associations between time-use and sleep onset timing in children: A multilevel compositional data analysis.

Sleep health·2026
Same author

Accounting for unmet need in equitable healthcare resource allocation: Synopsis.

Health and social care delivery research·2026
Same author

Diet Cost and Affordability in Queensland: A Two-Year Cross-Sectional Study.

International journal of environmental research and public health·2026
Same author

Estimated health and economic effects of different salt reduction strategies on cardiovascular disease in Brazil: a microsimulation analysis.

Scientific reports·2026
Same author

Bidirectional Association Between Movement Behavior Composition and Body Composition in Children With Motor Coordination Difficulties and Typical Motor Development.

Journal of physical activity & health·2026

Related Experiment Video

Updated: Jan 23, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

820

Analysis of the decrease in deaths due to coronary disease between 1995 and 2010. IMPACT CHD Argentina Study.

Jimena Vicens1, Gastón Perman, Valeria Aliperti

  • 1Hospital Italiano de Buenos Aires. Instituto Universitario Hospital Italiano.. jimena.vicens@hospitalitaliano.org.ar.

Revista De La Facultad De Ciencias Medicas (Cordoba, Argentina)
|June 20, 2019
PubMed
Summary
This summary is machine-generated.

Treatments accounted for half of the coronary heart disease mortality reduction in Argentina from 1995-2010, while improved risk factors contributed one-third. Declines in blood pressure, cholesterol, and smoking were offset by rising obesity and diabetes.

Keywords:
coronary diseaserisk factorstherapeuticsmortalityepidemiology

More Related Videos

High Throughput Analysis of Liquid Droplet Impacts
09:00

High Throughput Analysis of Liquid Droplet Impacts

Published on: March 6, 2020

7.0K
Analysis of Coronary Vessels in Cleared Embryonic Hearts
08:25

Analysis of Coronary Vessels in Cleared Embryonic Hearts

Published on: December 7, 2016

8.6K

Related Experiment Videos

Last Updated: Jan 23, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

820
High Throughput Analysis of Liquid Droplet Impacts
09:00

High Throughput Analysis of Liquid Droplet Impacts

Published on: March 6, 2020

7.0K
Analysis of Coronary Vessels in Cleared Embryonic Hearts
08:25

Analysis of Coronary Vessels in Cleared Embryonic Hearts

Published on: December 7, 2016

8.6K

Area of Science:

  • Cardiovascular Epidemiology
  • Public Health

Background:

  • Coronary heart disease (CHD) remains a leading cause of mortality globally.
  • Understanding the drivers of mortality reduction is crucial for effective public health strategies.

Purpose of the Study:

  • To quantify the impact of risk factor management and medical treatments on reducing CHD mortality in Argentina.
  • To analyze changes in CHD mortality between 1995 and 2010.

Main Methods:

  • Utilized the validated IMPACTCHD model.
  • Integrated data on treatment effectiveness, treatment uptake, and shifts in major risk factors.
  • Analyzed data for individuals over 25 years old in Argentina.

Main Results:

  • Medical treatments were responsible for approximately 50% of the observed reduction in CHD mortality.
  • Improvements in risk factors accounted for about one-third of the mortality decrease.
  • Reductions in blood pressure, cholesterol, and smoking were counteracted by increases in obesity, sedentary lifestyles, and diabetes prevalence.

Conclusions:

  • Both medical interventions and risk factor modifications significantly contributed to lowering CHD mortality in Argentina.
  • Addressing the rising prevalence of obesity, sedentary behavior, and diabetes is critical for further CHD prevention.
  • Collaborative efforts in cardiovascular epidemiology are vital for such analyses.